P2RY12 and myeloid sarcoma: Also, binding of P2X7 PET ligand was increased in multiple sclerosis (MS) active lesions, whereas the signal of the P2Y12-PET ligand was decreased in all MS lesions (active, chronic active and chronic inactive) (Beaino et al., 2017).